Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice

Introduction  Phase 3 trials have shown comparable efficacy of direct oral anticoagulants (DOACs) and vitamin K antagonists in patients with acute venous thromboembolism (VTE), with less major bleeding events in patients randomized to DOAC treatment. With DOACs being increasingly used in clinical pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriks, Stephan V., Klok, Frederikus A., Stenger, Wilhelmina J.E., Mairuhu, Albert T.A., Eikenboom, Jeroen, Fogteloo, Jaap, Huisman, Menno V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314657/
https://www.ncbi.nlm.nih.gov/pubmed/32607465
http://dx.doi.org/10.1055/s-0040-1713683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314657/
https://www.ncbi.nlm.nih.gov/pubmed/32607465
http://dx.doi.org/10.1055/s-0040-1713683

Ejemplares similares